Introduction {#Sec1}
============

Diabetes mellitus (DM) is the most common metabolic disease worldwide \[[@CR1]\]. It is characterized by disturbances in the circulating blood glucose levels that ultimately lead to hyperglycemia. DM is diagnosed based on specific circulating blood plasma glucose levels. The most commonly employed diagnostic indicators of DM are fasting plasma glucose levels of ≥ 126 mg/dl, an oral glucose tolerance test result of ≥ 200 mg/dl, checked 2 h after a glucose loading of 75 g (2-h plasma glucose), and glycosylated hemoglobin (HbA1c) levels of ≥ 6.5% \[[@CR2]\].

According to the World Health Organization, there are currently approximately 280 million diabetic individuals globally, with the expectation that the prevalence of DM will double by the year 2025 \[[@CR1]\]. Alarmingly, the areas of the Middle East and North Africa have a higher prevalence of DM than other parts of the world \[[@CR3]\], which means that patients in these regions are also at a higher risk of developing diabetes-related complications. The Kingdom of Saudi Arabia (KSA) is among the top-ten countries with the highest prevalence of DM in the world \[[@CR4]\], a dubious honor that is mainly attributed to lifestyle changes \[[@CR3]\]. Physical inactivity and a sluggish lifestyle, secondary to economic betterment, are the main contributors to the decreased life expectancy in the KSA \[[@CR5]\].

There are two main types of DM, namely, type 1 DM (T1DM) and type 2 DM (T2DM), and these differ in terms of age of onset and pathology. T1DM, or insulin-dependent DM (sometimes known as juvenile diabetes), is a consequence of autoimmune disease. In T1DM, the natural immune system of the body damages beta cells of the pancreas, rendering them unable to produce insulin. In comparison, T2DM, or insulin-independent DM, occurs at a later age and has a multifactorial etiology \[[@CR6]\]. T2DM is much more common than T1DM 1 \[[@CR7]\].

DM affects the vasculature of the eyes, which leads to various disorders, such as glaucoma, vitreous hemorrhage, cataracts, diabetic retinopathy, and blindness. Diabetic retinopathy, the most common disorder affecting the eyes of patients with DM \[[@CR8]\], is a progressive blood vessel disorder of the retina that is becoming one of the main causes of blindness in the age group of 20--60 years worldwide \[[@CR1]\]. It is estimated that, worldwide, 15,000--39,000 patients will lose their vision due to DM \[[@CR1]\].

Assessing awareness among diabetics is a necessary educational measure to help in the control of DM. Eye complications due to DM, such as retinopathy, can lead to high social and economic burdens. Currently, information on the level of such awareness in Jeddah City is lacking. Therefore, the aim of this study was to assess the level of awareness of DM complications, specifically eye complications, among adult diabetic patients attending the Jeddah Eye Hospital.

Methods {#Sec2}
=======

A cross-sectional study was conducted in Jeddah Eye Hospital, which is a government-funded hospital located in Jeddah (the commercial capital of KSA).

The sample size was calculated by using Jeddah Eye Hospital statistics from 2014, which showed that 85,000--95,000 patients visited the outpatient clinics of this hospital during that year. OpenEpi (<http://www.openepi.com>), an open-source software program, was used to calculate the sample size for a confidence interval (CI) of 95% and a margin of error of 0.05, and indicated that 380 participants would be necessary.

Consequently, 380 patients were recruited from the outpatient department of the hospital, either by referral from a primary healthcare center or through an appointment/consultation in the department. Patients were included in the study by choosing the first patient of the day and thereafter every third patient on the appointment list. Visitors of any nationality and gender who attended the outpatient department of Jeddah Eye Hospital during June to July 2015 and who had been previously diagnosed with DM were eligible for inclusion in the study. Patients who were seriously ill, in-patients, and those not able to give valid informed consent were excluded.

A 26-item closed-ended questionnaire was administered to the 380 randomly selected participants (see Electronic Supplementary Material Appendix). The questionnaire was designed after a detailed literature review; the main sources were the Behavioral Risk Factor Surveillance System Questionnaire (2012 and 2014) \[[@CR9], [@CR10]\] and the questionnaire developed by Tajunisah et al. for evaluating awareness of eye complications among patients with T2DM \[[@CR1]\]. The questionnaire was translated into Arabic for ease of use by the participants. There were two sets of questions; one set was used to obtain demographic data, the type of DM, modality of treatment, and time between diagnoses and referral to the eye clinic; the second set was used to assess the knowledge of the patient regarding diabetic eye complications, eye screening, and eye care seeking behavior.

The data provided by the completed questionnaires were transferred by the author into an electronic format using the electronic form functionality in Adobe Acrobat X Pro (Adobe Systems Incorporated, Austin, TX, USA) and subsequently exported as an XML file that was analyzed using SAS version 9.4 software (SAS Institute, Cary, NC, USA). The Chi-square test was utilized to test the association of dependent and independent variables and association of all independent variables. *t* tests were utilized to test the association between continuous variables. *P* values of \< 0.05 were considered to indicate statistical significance.

Compliance with Ethics Guidelines {#Sec3}
---------------------------------

All procedures performed in studies involving human participants were in accordance with the institutional review board (IRB) of Emory University (Atlanta, GA, USA) and with the 1964 Helsinki declaration and its later amendments, or comparable ethical standards. It was classified as public health practice and therefore not subject to review as "human subjects research"(IRB00081503). It was also approved by the local IRB of the Ministry of Health, KSA, (MOH trial registration no. 00611, approval no. A00277). Informed consent was obtained from all individual participants included in the study.

Results {#Sec4}
=======

The mean age of the patients was 58.3 years (standard deviation 10.9 years). Of the 380 participants, 291 resided in Jeddah, and 52.4% were female (Table [1](#Tab1){ref-type="table"}). Among the total patient group, 89.7% had T2DM; the remainder had T1DM. In terms of treatment, 41.9% of participants were on insulin. In total, 91.8% of patients had visited the doctor for an assessment of their DM before the year in which this study was conducted (Table [2](#Tab2){ref-type="table"}).Table 1Demographic characteristics of the 380 study participantsVariablesValueAge (years) 0--4531 (8.2) 45--5586 (22.6) 55--65154 (40.5) ≥ 65109 (28.7)Sex Male181 (47.6) Female199 (52.4)Nationality Saudi332 (87.4) Non-Saudi48 (12.6)Residency Inside Jeddah291 (76.6) Outside Jeddah89 (23.4)Primary healthcare center Followed up255 (67.1) Not followed up125 (32.9)Educational level Illiterate168 (44.2) Primary school70 (18.4) Preparatory school146 (12.1) Secondary school49 (12.9) University and higher degree47 (12.4)Values in table are presented as a number with the percentage of total patient population (*N* = 380) in parenthesis Table 2Association between different clinical variables and sexClinical variablesFemaleMaleTotal*p* valueDiabetes type Type 115 (8.3%)8 (4.0%)23 (6.1%)0.217 Type 2159 (87.8%)182 (91.5%)341 (89.7%) Unknown7 (3.9%)9 (4.5%)16 (4.2%)Use of insulin Yes79 (43.9%)79 (40.1%)158 (41.9%)0.45 No101 (56.1%)118 (59.9%)219 (58.1%)Seen by doctor in past 12 months Yes168 (92.8%)181 (91.0%)349 (91.8%)0.326 No13 (7.2%)18 (9.0%)31 (8.2%)Follow-up recommendation \< 4 visits in the last 12 months76 (43.7%)62 (31.8%)138 (37.4%)0.015 ≥ 4 visits in the last 12 months98 (56.3%)133 (68.2%)231 (62.6%)Glucose check-up frequencies31 (17.3%)26 (13.1%)57 (15.1%)0.196 Never46 (25.7%)78 (39.2%)124 (32.8%) \< 4 times a day6 (3.4%)2 (1.0%)8 (2.1%) \> 4 times a day31 (17.3%)34 (17.1%)65 (17.2%) \< 4 times a month61 (34.1%)58 (29.1%)119 (31.5%) \> 4 times a month4 (2.2%)1 (0.5%)5 (1.3%)Eye screening referral Yes121 (33.2%)134 (67.3%)255 (67.1%)0.784 No60 (66.8%)65 (32.7%)125 (32.9%)Time between diagnosis and eye screening Between 0 and 10 years79 (44.6%)73 (37.6%)152 (41.0%)0.219 Between 10 and 20 years51 (28.8%)72 (37.1%)123 (33.1%) \> 20 years47 (26.6%)49 (25.3%)96 (25.9%)Wear eyeglasses or contact lenses Yes109 (60.2%)129 (65.5%)238 (62.9%)0.259 No72 (39.8%)68 (34.5%)140 (37.1%)Last eye examination Never14 (7.8%)15 (7.5%)29 (7.6%)0.29 Don't know/not sure8 (4.4%)4 (2.0%)12 (3.2%) Within past year142 (78.9%)169 (85.0%)311 (82.1%) \> 1 year16 (8.9%)11 (5.5%)27 (7.1%)Retinopathy Yes119 (66.1%)134 (67.7%)253 (66.9%)0.739 No55 (30.6%)56 (28.3%)111 (29.4%) Don't know/not sure6 (3.3%)8 (4.0%)14 (3.7%)HbA1C (glycosylated hemoglobin A1c) \> 6.5%52 (96.3%)76 (96.2%)128 (96.2%)0.978 \< 6.5%2 (3.7%)3 (3.8%)5 (3.8%)Values in table are presented as a number with the percentage of total patient population (*N* = 380) in parenthesis

In terms of knowledge of DM complications, 92.4% of the participants were aware that DM can lead to eye disease; 5% thought that DM has no effect on eyes, whereas 2.6% did not know anything about diabetes-related eye diseases (Table [3](#Tab3){ref-type="table"}).Table 3Knowledge of diabetes-related complications among participantsComplicationYes, patient was aware that diabetes can lead to eye diseaseNo, patient was not aware that diabetes has an effect on eyesPatient knew nothing about diabetes-related eye diseasesCoronary artery disease246 (64.7)65 (17.1)69 (18.2)Stroke228 (60.2)72 (19.0)79 (20.8)Peripheral vascular disease236 (62.3)61 (16.1)82 (21.6)Neuropathy259 (68.5)67 (17.7)52 (13.8)Eye disease351 (92.4)19 (5.0)10 (2.6)Nephropathy269 (70.8)69 (18.2)42 (11.0)Values in table are presented as a number with the percentage of total patient population (*N* = 380) in parenthesis

Of the participants, 81.7% agreed to have their eyes checked, even when their blood glucose was in the normal range (Table [4](#Tab4){ref-type="table"}). Similarly, when asked about the frequency of eye check-up visits, 69.5% of participants answered that they considered that eye check-ups should be conducted at 6-month intervals, 19.2% answered that eye check-ups should be performed when there is a problem with vision, while 10.5% considered that yearly eye check-ups were adequate (Table [5](#Tab5){ref-type="table"}).Table 4Knowledge of eye check-up frequency when blood sugar levels are controlledEye check-up even though blood sugar levels are normalValuesYes308 (81.7)No52 (13.8)Sometimes17 (4.5)Values in table are presented as a number with the percentage of total patient population (*N* = 380) in parenthesis Table 5Knowledge about eye check-up frequencyEye check-up frequencyValueEvery 6 months264 (69.5)Only when vision is affected73 (19.2)Two-yearly interval3 (0.8)Yearly40 (10.5)Values in table are presented as a number with the percentage of total patient population (*N* = 380) in parenthesis

When asked about the source of information from which they obtained knowledge about the complications of DM, 67.2% participants answered that health-care workers were their source of information, 18.0% answered that routes of mass communication provided them with information, while 14.8% obtained their information from their relatives or friends (Table [6](#Tab6){ref-type="table"}).Table 6Source of knowledge about complicationsSource of informationValueDoctor/nurse/ophthalmologist/optometrist254 (67)Family member/friends/relative with diabetes56 (14.8)Television/radio/newspaper/Internet68 (18)Values in table are presented as a number with the percentage of total patient population (*N* = 380) in parenthesis

The level of awareness about complications of DM was significantly associated with level of education (*p* \< 0.05) (Fig. [1](#Fig1){ref-type="fig"}). The source of the patient's information was also significantly associated with awareness (*p* \< 0.05). Participants who gained their knowledge from mass media had a higher level of awareness than those who gained their knowledge from healthcare professionals (Fig. [2](#Fig2){ref-type="fig"}). The area of residency was also significantly associated with the patient's awareness (*p* \< 0.05). Residents of Jeddah had a higher awareness of DM eye complications than those from outside this city.Fig. 1Level of awareness about complications of diabetes mellitus according to level of education. *HIG* High level of awareness, *LOW* low level of awareness, *MED* medium level of awareness Fig. 2Level of awareness about complications of diabetes mellitus according to source of knowledge. *HIG* High level of awareness, *LOW* low level of awareness, *MED* medium level of awareness

Discussion {#Sec5}
==========

A study published in 2016 showed that the prevalence of pre-diabetes among the adult population of Jeddah was 9.0% (8.6% in women and 9.4% in men) \[[@CR11]\]. The overall prevalence of diabetic retinopathy in the KSA ranges between 33 and 36% in different regions \[[@CR12]\].

The proportion of participants (66.9%) diagnosed with diabetic retinopathy in this study was higher than that reported in 2012 in a study conducted by El-Bab et al. in the city of Al-Madinah Al-Munawarah (36.1%) \[[@CR13]\]. However, 92% of the participants in the present study were aware of the effects of DM on eyes, which is higher than ever previously reported in a study conducted in the KSA. Tajunishah et al. reported that 86.1% participants were aware of DM causing eye diseases \[[@CR1]\], whereas the authors of a hospital-based study conducted in India concluded that only 51% people had knowledge of the association between DM and eye diseases \[[@CR14]\].

In the present study, follow-up with healthcare professionals (based on recommended guidelines) and level of awareness were significantly associated. In contrast, Addoor and Bhandary reported that among the diabetics attending peripheral diabetic clinics in Melaka, Malaysia, there was no statistically significant effect of previous follow-up visits for DM on the level of awareness \[[@CR15]\].

Educated individuals participating in this study had a better understanding of the need for follow-up and the frequency of eye check-ups. Education enhances awareness and thus plays a key role in the development of a healthy society \[[@CR1]\]. The patients with secondary or graduate level education in our study were well aware of diabetes-related conditions. Malaysian and South African studies have also demonstrated similar results \[[@CR9], [@CR16]\]. Clearly, individuals who are well educated have better access to different modes of mass communication and are better empowered to understand their health condition.

In the present study, 67.2% of the patients had obtained information about diabetes-related eye complications from healthcare providers, while 18% of the patients had obtained this information from mass media. In a U.S. study on Hispanics, around 60% of the patients had obtained their diabetes-related knowledge from healthcare providers \[[@CR17]\]. In the present study it was also evident that although the proportion of individuals obtaining this knowledge from mass media was smaller than that obtaining information from healthcare providers, the former had a better understanding of their disease. This result clearly questions the level of awareness instilled by healthcare providers as it would appear that mass media was more effective in conveying its message across the population. This finding also suggests that healthcare workers should be trained in developing effective communication skills, as they have to deal with many illiterate patients; the percentage of illiterate individuals in this study was 44.2%.

Inadequate awareness of diabetic eye complications is the main barrier preventing patients from having earlier eye check-ups, as indicated by the prevalance of inadequate awareness in the present study (62.8%). Lack of knowledge was also the main barrier to attending regular check-ups in the above-mentioned Malaysian study \[[@CR9]\]. Clearly, an increase in public awareness will lead to a decreased incidence of diabetic retinopathies \[[@CR5]\].

Limitations {#Sec6}
-----------

Actually the study was conducted from June 1 to July 30, which included the Muslims' month of fasting (Ramadan). Data collection may have been affected by factors related to this observance, such as type of patients showing up for appointments during this month and the reduced working hours. Moreover, the study was a hospital-based study conducted in one specialized eye hospital; a similar study might need to be conducted in a public or non-specialized hospital to validate the results. Very limited access to medical records was a barrier to obtaining data on HbA1c levels, and the study relied on participants to report this data, which may have introduced a recall bias.

Conclusions {#Sec7}
===========

The results of this study show that although a high percentage of the participants were aware of diabetes-related complications in general and eye diseases specifically, they did not have sufficient knowledge to prevent and manage these. The awareness that is instilled via healthcare providers, such as doctors and nurses, is inefficient. Different courses and lectures should be designed for healthcare workers to improve their communication skills. The results reported here indicate that mass media is more effective in instilling awareness and understanding of diabetes-related complications due to its ability to raise important health issues that reflect public concerns. Health messages delivered through mass media should be simple, creative, use different formats, and be repeated many times. It should be noted that these messages are unlikely to lead to the development of skills or to change behaviors, but they can provide the right information, which is a step toward increasing the patient's level of awareness.
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